Marco Cefalì

Here below are the publications (1) participated by Marco Cefalì along with Genti Xhepa (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations).

Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) Body composition as a predictor of chemotherapy-related toxicity in pancreatic cancer patients: A systematic review

Frontiers in Oncology, 29 settembre 2022

Facts & figures

Marco Cefalì has coordinated or participated in 3 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) whose subjects can be represented by this 15 elements tag cloud:

18F-FDG PET (1) bevacizumab (1) body composition (1) chemotherapy (1) complete clinical response (1) metastatic colorectal cancer (1) neoadjuvant chemoradiotherapy (1) next-generation sequencing (1) oesophageal cancer (1) pancreatic cancer (1) pathological complete response (1) radiomics (1) RAS mutations (1) sarcopenia (1) toxicity (1)

Marco Cefalì has coordinated or participated in 3 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) featured by 2 scientific journals:

Frontiers in Oncology (2) Oncotarget (1)

Marco Cefalì has coordinated or participated in 3 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) involving also 17 co-authors being active in Ticino:

Sara De Dosso (3) Stefano Cappio (2) Maria Celeste Palmarocchi (1) Letizia Deantonio (1) Davide La Regina (1) Samantha Epistolio (1) Paolo Spina (1) Stefania Rizzo (1) Francesca Molinari (1) Genti Xhepa (1) Maria Carla Valli (1) Gaetano Paone (1) Piercarlo Saletti (1) Milo Frattini (1) Luca Mazzucchelli (1) Isabel Scala (1) Filippo Del Grande (1)

Marco Cefalì has coordinated or participated in 3 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) in whose synopsis the 14 most frequently used terms (excluding 16 not relevant terms) are here listed:

M.C. WORD CLOUD cancer (3) occurence (1) ras (1) reversion (1) metastatic (1) colorectal (1) bevacizumab (1) f-fdg (1) pet (1) radiomics (1) oesophageal (1) chemotherapy-related (1) toxicity (1) pancreatic (1)

In the synopsis of the whole 3139 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations), the 173 most frequently used terms (excluding 16 not relevant or unfrequently used terms (terms used less than 10 times) are here listed:

THE WHOLE WORD CLOUD cancer (281) covid- (182) thyroid (108) sars-cov- (102) prostate (101) pet (101) cardiac (97) hiv (83) atrial (75) coronary (75) breast (74) pandemic (67) sclerosis (67) lymphoma (66) fibrillation (65) bone (53) aortic (51) artery (49) heart (48) liver (46) stroke (46) brain (43) carcinoma (43) antibodies (41) lung (38) mri (38) cardiovascular (36) transcatheter (35) ventricular (35) nodules (34) dna (34) virus (33) extracellular (32) metastatic (32) myocardial (31) tumor (30) kidney (29) oncology (29) ultrasound (28) knee (27) esmo (26) f-fdg (26) antibody (26) vesicles (25) spinal (25) mitral (25) hepatitis (24) ischemic (23) cervical (23) infarction (22) tuberculosis (22) ehra (22) antiplatelet (22) diabetes (22) sperm (22) pulmonary (21) radiotherapy (21) chemotherapy (21) renal (21) ovarian (21) percutaneous (21) osteoarthritis (20) implantation (20) vaccination (20) sentinel (20) transplantation (19) blood (19) nuclear (18) urinary (18) tomography (18) pacing (18) tumors (18) bacterial (18) b-cell (17) resonance (17) endovascular (17) monoclonal (17) bladder (17) lymph (17) laparoscopic (17) colorectal (17) mice (17) coronavirus (16) immunodeficiency (16) transplant (15) musculoskeletal (15) vascular (15) fdg (15) implantable (15) lymphomas (14) plasma (14) vaccine (14) fractures (14) peripheral (14) neurocognitive (14) leukemia (14) autoimmune (13) mrna (13) biomarker (13) nerve (13) pneumonia (13) biomarkers (13) radiomics (13) metabolic (13) tricuspid (13) preclinical (13) metabolism (13) serum (13) metastasis (13) pregnancy (13) lymphocytic (13) conference (12) malignancy (12) membrane (12) grafts (12) ischemia (12) endometrial (12) fna (12) joint (12) brugada (12) antiretroviral (12) legs (12) male (12) arterial (12) dementia (12) esc (12) hemorrhage (12) behavior (12) pi (11) burden (11) cytology (11) signaling (11) pathways (11) contemporary (11) adherence (11) catheter (11) contrast-enhanced (11) limb (11) tau (11) parkinson (11) radiation (11) senescence (11) neck (11) hiv- (11) mesenchymal (11) lockdown (11) mutations (11) medullary (11) il- (11) infectious (10) cancers (10) igg (10) intravenous (10) arrhythmia (10) vitamin (10) interventions (10) prophylaxis (10) migraine (10) follicular (10) gastric (10) prognosis (10) metastases (10) skin (10) incontinence (10) muscle (10) anesthesia (10) epidemiology (10) lipid (10) baseline (10) refractory (10) malignant (10) occlusion (10) dynamic (10)

Scientific researchers in Ticino

Marco Cefalì has participated - as a whole - in 3 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) - here below are the ones participated along with Genti Xhepa

1) Body composition as a predictor of chemotherapy-related toxicity in pancreatic cancer patients: A systematic review

Marco Cefalì has participated - as a whole - in 3 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) - here below are the ones participated along with Genti Xhepa